Top Banner
USP Medicare Model Guidelines v7.0 Page 1 of 38 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 A B D E F USP Category USP Class Example Part D Eligible Drugs* Salt/Ester Change Language Analgesics Analgesics Nonsteroidal Anti-inflammatory Drugs Analgesics Celecoxib Analgesics Diclofenac Potassium Analgesics Diflunisal Analgesics Etodolac Analgesics Fenoprofen Calcium Analgesics Flurbiprofen Analgesics Ibuprofen Analgesics Indomethacin Analgesics Ketoprofen Analgesics Ketorolac Tromethamine Analgesics Meclofenamate Analgesics Mefenamic Acid Analgesics Meloxicam Analgesics Nabumetone Analgesics Naproxen Analgesics Oxaprozin Analgesics Piroxicam Analgesics Sulindac Analgesics Tolmetin Analgesics Opioid Analgesics, Long-acting Analgesics Buprenorphine FDA approved 10/23/2015; New indication for pain Fentanyl Analgesics Hydromorphone Analgesics Levorphanol Tartrate Analgesics Methadone Hydrochloride Analgesics Morphine Sulfate Analgesics Oxycodone Hydrochloride Analgesics Oxymorphone Hydrochloride Analgesics Tramadol Hydrochloride Analgesics Opioid Analgesics, Short-acting Analgesics Butorphanol Tartrate Analgesics Codeine Phosphate Analgesics Fentanyl Citrate Analgesics Hydromorphone Hydrochloride Analgesics Meperidine Hydrochloride Analgesics Nalbuphine Hydrochloride Analgesics Oxycodone Hydrochloride Analgesics Oxymorphone Hydrochloride Analgesics Pentazocine Lactate Analgesics Tapentadol Analgesics Tramadol Hydrochloride Anesthetics Anesthetics Local Anesthetics Anesthetics Lidocaine Hydrochloride Anesthetics Lidocaine/Prilocaine Anti-Addiction/ Substance Abuse Treatment Agents Alcohol Deterrents/Anti-craving Acamprosate Calcium * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red
38

USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

May 12, 2018

Download

Documents

vuxuyen
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 1 of 38

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

Analgesics

Analgesics Nonsteroidal Anti-inflammatory Drugs

Analgesics Celecoxib

Analgesics Diclofenac Potassium

Analgesics Diflunisal

Analgesics Etodolac

Analgesics Fenoprofen Calcium

Analgesics Flurbiprofen

Analgesics Ibuprofen

Analgesics Indomethacin

Analgesics Ketoprofen

Analgesics Ketorolac Tromethamine

Analgesics Meclofenamate

Analgesics Mefenamic Acid

Analgesics Meloxicam

Analgesics Nabumetone

Analgesics Naproxen

Analgesics Oxaprozin

Analgesics Piroxicam

Analgesics Sulindac

Analgesics Tolmetin

Analgesics Opioid Analgesics, Long-acting

Analgesics Buprenorphine FDA approved 10/23/2015; New indication for

pain

Fentanyl

Analgesics Hydromorphone

Analgesics Levorphanol Tartrate

Analgesics Methadone Hydrochloride

Analgesics Morphine Sulfate

Analgesics Oxycodone Hydrochloride

Analgesics Oxymorphone Hydrochloride

Analgesics Tramadol Hydrochloride

Analgesics Opioid Analgesics, Short-acting

Analgesics Butorphanol Tartrate

Analgesics Codeine Phosphate

Analgesics Fentanyl Citrate

Analgesics Hydromorphone Hydrochloride

Analgesics Meperidine Hydrochloride

Analgesics Nalbuphine Hydrochloride

Analgesics Oxycodone Hydrochloride

Analgesics Oxymorphone Hydrochloride

Analgesics Pentazocine Lactate

Analgesics Tapentadol

Analgesics Tramadol Hydrochloride

Anesthetics

Anesthetics Local Anesthetics

Anesthetics Lidocaine Hydrochloride

Anesthetics Lidocaine/Prilocaine

Anti-Addiction/ Substance Abuse

Treatment Agents

Alcohol Deterrents/Anti-craving

Acamprosate Calcium

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 2: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 2 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

Disulfiram

Naltrexone Hydrochloride

Opioid Dependence Treatments

Buprenorphine

Buprenorphine/Naloxone

Naltrexone Hydrochloride

Opioid Reversal Agents

Naloxone Hydrochloride

Smoking Cessation Agents

Bupropion Hydrochloride

Nicotine

Varenicline Tartrate

Antibacterials

Antibacterials Aminoglycosides

Antibacterials Amikacin Sulfate

Antibacterials Gentamicin Sulfate

Antibacterials Kanamycin Sulfate

Antibacterials Neomycin Sulfate

Antibacterials Paromomycin Sulfate

Antibacterials Streptomycin Sulfate

Antibacterials Tobramycin Sulfate

Antibacterials Tobramycin/ Dexamethasone

Antibacterials Beta-lactam, Cephalosporins

Antibacterials

Antibacterials Cefadroxil

Antibacterials Cefazolin

Antibacterials Cephalexin

Antibacterials

Antibacterials Cefaclor

Antibacterials Cefoxitin

Antibacterials Cefprozil

Antibacterials Cefuroxime Axetil

Antibacterials

Antibacterials Cefdinir

Antibacterials Cefditoren Pivoxil

Antibacterials Cefixime

Antibacterials Cefotaxime

Antibacterials Cefpodoxime Proxetil

Antibacterials Ceftazidime

Antibacterials Ceftazidime/Avibactam New FDA Approved Drug, 2/25/15

Antibacterials Ceftibuten Dihydrate

Antibacterials Ceftriaxone Sodium

Antibacterials

Antibacterials Cefepime Hydrochloride

Antibacterials Ceftolozane Sulfate/

Tazobactam

New FDA Approved Drug, 12/19/14

Antibacterials

Antibacterials Ceftaroline fosamil

Antibacterials Beta-lactam, Penicillins

Antibacterials

Antibacterials Amoxicillin

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 3: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 3 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

Antibacterials Amoxicillin/Clavulanate

Potassium

Antibacterials Ampicillin

Antibacterials Ampicillin Sodium/ Sulbactam

Sodium

Antibacterials

Antibacterials Piperacillin Sodium

Antibacterials Piperacillin Sodium/

Tazobactam Sodium

Antibacterials Ticarcillin Disodium/

Clavulanate Potassium

Discontinued by manufacturer

Antibacterials

Antibacterials Penicillin G Benzathine

Antibacterials Potassium

Antibacterials Procaine

Antibacterials Sodium

Antibacterials Penicillin V Potassium

Antibacterials

Antibacterials Dicloxacillin Sodium

Antibacterials Nafcillin Sodium

Antibacterials Oxacillin Sodium

Antibacterials Beta-lactam, Other

Antibacterials Aztreonam

Antibacterials Doripenem

Antibacterials Ertapenem Sodium

Antibacterials Imipenem/Cilastatin Sodium

Antibacterials Meropenem

Antibacterials Macrolides

Antibacterials Azithromycin

Antibacterials Clarithromycin

Antibacterials Erythromycin Estolate

Antibacterials Ethylsuccinate

Antibacterials Lactobionate

Antibacterials Stearate

Antibacterials Fidaxomicin

Antibacterials Telithromycin Discontinued by manufacturer

Antibacterials Quinolones

Antibacterials Besifloxacin

Antibacterials Ciprofloxacin

Antibacterials Finafloxacin New FDA Approved Drug, 12/17/14

Antibacterials Gatifloxacin

Antibacterials Gemifloxacin Mesylate

Antibacterials Levofloxacin

Antibacterials Moxifloxacin Hydrochloride

Antibacterials Norfloxacin Discontinued by manufacturer

Antibacterials Ofloxacin

Antibacterials Sulfonamides

Antibacterials Sulfacetamide Sodium

Antibacterials Sulfadiazine

Antibacterials Sulfamethoxazole/

Trimethoprim

Antibacterials Tetracyclines

Antibacterials Demeclocycline Hydrochloride

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 4: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 4 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

Antibacterials Doxycycline Calcium

Antibacterials Hyclate

Antibacterials Minocycline Hydrochloride

Antibacterials Tetracycline Hydrochloride

Antibacterials Antibacterials, Other

Antibacterials

Antibacterials

Antibacterials Trimethoprim

Antibacterials

Antibacterials Vancomycin Hydrochloride

Antibacterials Dalbavancin New FDA Approved Drug, 5/23/14

Antibacterials

Antibacterials Clindamycin Hydrochloride

Antibacterials Palmitate

Antibacterials Lincomycin Hydrochloride

Antibacterials

Antibacterials Nitrofurantoin

Antibacterials

Antibacterials Linezolid

Antibacterials Tedizolid Phosphate New FDA Approved Drug, 6/20/14

Antibacterials

Antibacterials Acetic Acid

Antibacterials Bacitracin

Antibacterials Chloramphenicol Sodium Succinate

Antibacterials Daptomycin

Antibacterials Fosfomycin Tromethamine

Antibacterials Gramicidin

Antibacterials Mafenide Acetate

Antibacterials Methenamine Hippurate

Antibacterials Mandelate

Antibacterials Metronidazole Hydrochloride

Antibacterials Mupirocin Calcium

Antibacterials Polymyxin B Sulfate

Antibacterials Retapamulin

Antibacterials Rifaximin

Antibacterials Telavancin

Antibacterials Tinidazole

Antibacterials Tigecycline

Antibacterials Oritavancin New FDA Approved Drug, 8/9/14

Anticonvulsants

Anticonvulsants Calcium Channel Modifying Agents

Anticonvulsants Ethosuximide

Anticonvulsants Methsuximide

Anticonvulsants Pregabalin

Anticonvulsants Zonisamide

Anticonvulsants Gamma-aminobutyric Acid (GABA)

Augmenting Agents

Anticonvulsants

Anticonvulsants Clobazam

Anticonvulsants Clonazepam

Anticonvulsants Clorazepate Dipotassium

Anticonvulsants Diazepam

Anticonvulsants Lorazepam

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 5: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 5 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

Anticonvulsants

Anticonvulsants Mephobarbital Discontinued by manufacturer

Anticonvulsants Phenobarbital

Anticonvulsants Primidone

Anticonvulsants

Anticonvulsants Divalproex Sodium

Anticonvulsants Gabapentin

Anticonvulsants Tiagabine Hydrochloride

Anticonvulsants Valproate Sodium

Anticonvulsants Vigabatrin

Anticonvulsants Glutamate Reducing Agents

Anticonvulsants Felbamate

Anticonvulsants Lamotrigine

Anticonvulsants Perampanel

Anticonvulsants Topiramate

Anticonvulsants Sodium Channel Agents

Anticonvulsants Carbamazepine

Anticonvulsants Eslicarbazepine Acetate

Anticonvulsants Ethotoin

Anticonvulsants Fosphenytoin Sodium

Anticonvulsants Oxcarbazepine

Anticonvulsants Phenytoin Sodium

Anticonvulsants Rufinamide

Anticonvulsants

Anticonvulsants Lacosamide

Anticonvulsants Anticonvulsants, Other

Anticonvulsants Briavaracetam New FDA Approved Drug, 2/18/16

Anticonvulsants Levetiracetam

Anticonvulsants

Anticonvulsants Ezogabine

Antidementia Agents

Antidementia Agents Cholinesterase Inhibitors

Antidementia Agents Donepezil Hydrochloride

Antidementia Agents Galantamine Hydrochloride

Antidementia Agents Rivastigmine Tartrate

Antidementia Agents N-methyl-D-aspartate (NMDA) Receptor

Antagonist

Antidementia Agents Memantine Hydrochloride

Antidementia Agents Antidementia Agents, Other

Antidementia Agents Ergoloid Mesylates

Antidepressants

Antidepressants Monoamine Oxidase Inhibitors

Antidepressants Phenelzine Sulfate

Antidepressants Selegiline

Antidepressants Tranylcypromine Sulfate

Antidepressants SSRIs/SNRIs (Selective Serotonin

Reuptake Inhibitors/ Serotonin and

Norepinephrine Reuptake Inhibitors)

Antidepressants Citalopram Hydrobromide

Antidepressants Desvenlafaxine

Antidepressants Duloxetine Hydrochloride

Antidepressants Escitalopram Oxalate

Antidepressants Fluoxetine Hydrochloride

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 6: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 6 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

Antidepressants Fluvoxamine Maleate

Antidepressants Levomilnacipran Hydrochloride

Antidepressants Maprotiline Hydrochloride

Antidepressants Nefazodone Hydrochloride

Antidepressants Paroxetine Hydrochloride

Antidepressants Sertraline Hydrochloride

Antidepressants Trazodone Hydrochloride

Antidepressants Venlafaxine Hydrochloride

Antidepressants Vilazodone Hydrochloride

Antidepressants Vortioxetine

Antidepressants Tricyclics

Antidepressants Amitriptyline Hydrochloride

Antidepressants Amoxapine

Antidepressants Clomipramine Hydrochloride

Antidepressants Desipramine Hydrochloride

Antidepressants Doxepin Hydrochloride

Antidepressants Imipramine Hydrochloride

Antidepressants Imipramine Pamoate

Antidepressants Nortriptyline Hydrochloride

Antidepressants Protriptyline Hydrochloride

Antidepressants Trimipramine Maleate

Antidepressants Antidepressants, Other

Antidepressants Bupropion Hydrochloride

Antidepressants Mirtazapine

Antidepressants

Antidepressants Aripiprazole

Antidepressants Quetiapine Fumarate

Antiemetics

Antiemetics Emetogenic Therapy Adjuncts

Antiemetics Netupitant/Palonosetron Hydrochloride New FDA Approved Drug, 10/10/14

Antiemetics Rolapitant New FDA Approved Drug, 9/1/15

Antiemetics

Antiemetics Dolasetron Mesylate

Antiemetics Granisetron Hydrochloride

Antiemetics Ondansetron Hydrochloride

Antiemetics Palonosetron Hydrochloride

Antiemetics

Antiemetics Aprepitant

Antiemetics

Antiemetics Dronabinol

Antiemetics Nabilone

Antiemetics Antiemetics, Other

Antiemetics Chlorpromazine Hydrochloride

Antiemetics Diphenhydramine Hydrochloride

Antiemetics Doxylamine Succinate/

Pyridoxine Hydrochloride

Antiemetics Hydroxyzine Pamoate

Antiemetics Meclizine Hydrochloride

Antiemetics Metoclopramide

Antiemetics Perphenazine

Antiemetics Prochlorperazine Edisylate

Antiemetics Maleate

Antiemetics Promethazine Hydrochloride

Antiemetics Scopolamine

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 7: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 7 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

Antiemetics Trimethobenzamide Hydrochloride

Antifungals

Antifungals

Antifungals Naftifine Hydrochloride

Antifungals Terbinafine Hydrochloride

Antifungals

Antifungals Butoconazole Nitrate

Antifungals Clotrimazole

Antifungals Econazole Nitrate

Antifungals Efinaconazole New FDA Approved Drug, 6/6/14

Antifungals Fluconazole

Antifungals Isavuconazonium New FDA Approved Drug, 3/6/15

Antifungals Itraconazole

Antifungals Ketoconazole

Antifungals Luliconazole

Antifungals Miconazole Nitrate

Antifungals Oxiconazole Nitrate

Antifungals Posaconazole

Antifungals Sertaconazole Nitrate

Antifungals Sulconazole Nitrate

Antifungals Terconazole

Antifungals Voriconazole

Antifungals

Antifungals

Antifungals Anidulafungin

Antifungals Caspofungin Acetate

Antifungals Micafungin Sodium

Antifungals

Antifungals Natamycin

Antifungals Nystatin

Antifungals

Antifungals Butenafine Hydrochloride

Antifungals Ciclopirox

Antifungals Flucytosine

Antifungals Griseofulvin

Antifungals Tavaborole New FDA Approved Drug, 7/7/14

Antigout Agents

Antigout Agents

Antigout Agents Probenecid

Antigout Agents

Antigout Agents Allopurinol

Antigout Agents Febuxostat

Antigout Agents

Antigout Agents Colchicine

Antigout Agents

Antigout Agents Lesinurad New FDA Approved Drug, 12/22/15

Anti-inflammatory Agents

Anti-inflammatory Agents Glucocorticoids

Anti-inflammatory Agents Nonsteroidal Anti-inflammatory Drugs

Anti-inflammatory Agents Celecoxib

Anti-inflammatory Agents Diclofenac Potassium

Anti-inflammatory Agents Diflunisal

Anti-inflammatory Agents Etodolac

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 8: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 8 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

389

390

391

392

393

394

395

396

397

398

399

400

401

402

403

404

405

406

407

408

Anti-inflammatory Agents Fenoprofen Calcium

Anti-inflammatory Agents Flurbiprofen

Anti-inflammatory Agents Ibuprofen

Anti-inflammatory Agents Indomethacin

Anti-inflammatory Agents Ketoprofen

Anti-inflammatory Agents Ketorolac Tromethamine

Anti-inflammatory Agents Meclofenamate Sodium

Anti-inflammatory Agents Mefenamic Acid

Anti-inflammatory Agents Meloxicam

Anti-inflammatory Agents Nabumetone

Anti-inflammatory Agents Naproxen Sodium

Anti-inflammatory Agents Oxaprozin

Anti-inflammatory Agents Piroxicam

Anti-inflammatory Agents Sulindac

Anti-inflammatory Agents Tolmetin Sodium

Antimigraine Agents

Antimigraine Agents Ergot Alkaloids

Antimigraine Agents Dihydroergotamine Mesylate

Antimigraine Agents Ergotamine Tartrate

Antimigraine Agents Serotonin (5-HT) 1b/1d Receptor Agonists

Antimigraine Agents Almotriptan Malate

Antimigraine Agents Eletriptan

Antimigraine Agents Frovatriptan Succinate

Antimigraine Agents Naratriptan Hydrochloride

Antimigraine Agents Rizatriptan Benzoate

Antimigraine Agents Sumatriptan

Antimigraine Agents Zolmitriptan

Antimigraine Agents Prophylactic

Antimigraine Agents

Antimigraine Agents Timolol Maleate

Antimigraine Agents

Antimigraine Agents Divalproex Sodium

Antimigraine Agents Topiramate

Antimigraine Agents Valproic Acid

Antimyasthenic Agents

Antimyasthenic Agents Parasympathomimetics

Antimyasthenic Agents Ambenonium Chloride Discontinued by manufacturer

Antimyasthenic Agents Guanidine Hydrochloride

Antimyasthenic Agents Pyridostigmine Bromide

Antimycobacterials

Antimycobacterials Antituberculars

Antimycobacterials Bedaquiline Fumerate

Antimycobacterials Capreomycin Sulfate

Antimycobacterials Cycloserine

Antimycobacterials Ethambutol Hydrochloride

Antimycobacterials Ethionamide

Antimycobacterials Isoniazid

Antimycobacterials Pyrazinamide

Antimycobacterials Rifampin

Antimycobacterials Rifampin/Isoniazid

Antimycobacterials Rifampin/Isoniazid/

Pyrazinamide

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 9: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 9 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

457

458

459

460

Antimycobacterials Rifapentine

Antimycobacterials Antimycobacterials, Other

Antimycobacterials Dapsone

Antimycobacterials Rifabutin

Antineoplastics

Antineoplastics Alkylating Agents

Antineoplastics

Antineoplastics Altretamine

Antineoplastics

Antineoplastics Chlorambucil

Antineoplastics Mechlorethamine hydrochloride

Antineoplastics Melphalan

Antineoplastics

Antineoplastics Lomustine

Antineoplastics

Antineoplastics Busulfan

Antineoplastics Cyclophosphamide

Antineoplastics Procarbazine Hydrochloride

Antineoplastics Trabectedin New FDA approved drug, 10/23/15

Antineoplastics Antiandrogens

Antineoplastics

Antineoplastics Enzalutamide

Antineoplastics Bicalutamide

Antineoplastics Flutamide

Antineoplastics Nilutamide

Antineoplastics

Antineoplastics Abiraterone Acetate

Antineoplastics Antiangiogenic Agents

Antineoplastics Lenalidomide

Antineoplastics Pomalidomide

Antineoplastics Thalidomide

Antineoplastics Antiestrogens/Modifiers

Antineoplastics

Antineoplastics Estramustine Phosphate

Sodium

Antineoplastics

Antineoplastics Tamoxifen Citrate

Antineoplastics Toremifene Citrate

Antineoplastics Antimetabolites

Antineoplastics

Antineoplastics Mercaptopurine

Antineoplastics Thioguanine

Antineoplastics

Antineoplastics Hydroxyurea

Antineoplastics Aromatase Inhibitors, 3rd Generation

Antineoplastics Anastrozole

Antineoplastics Exemestane

Antineoplastics Letrozole

Antineoplastics Enzyme Inhibitors

Antineoplastics Etoposide

Antineoplastics Topotecan

Antineoplastics Molecular Target Inhibitors

Antineoplastics Gefitinib New FDA approved drug, 7/13/15

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 10: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 10 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

488

489

490

491

492

493

494

495

496

497

498

499

500

501

502

503

504

505

506

507

508

509

510

511

512

513

514

515

Antineoplastics

Antineoplastics Cobimetinib New FDA Approved Drug, 11/10/15

Antineoplastics

Antineoplastics Alectinib New FDA Approved Drug, 12/11/15

Antineoplastics Ceritinib New FDA Approved Drug, 4/28/14

Antineoplastics Crizotinib

Antineoplastics

Antineoplastics Vemurafenib

Antineoplastics Dabrafenib

Antineoplastics Trametinib

Antineoplastics

Antineoplastics Ibrutinib

Antineoplastics

Antineoplastics Palbociclib New FDA Approved Drug, 2/3/15

Antineoplastics

Antineoplastics Ramucirumab New FDA Approved Drug, 4/24/15

Antineoplastics

Antineoplastics Afatinib Dimaleate

Antineoplastics Erlotinib Hydrochloride

Antineoplastics Osimertinib New FDA Approved Drug, 11/13/15

Antineoplastics

Antineoplastics Sonidegib New FDA Approved Drug, 7/24/15

Antineoplastics Vismodegib

Antineoplastics

Antineoplastics Ruxolitinib

Antineoplastics

Antineoplastics Cabazitaxel Part D eligibile drug (CY16 FRF v09.26.16)

Antineoplastics

Antineoplastics Everolimus

Antineoplastics

Antineoplastics Bosutinib

Antineoplastics Dasatinib

Antineoplastics Imatinib Mesylate

Antineoplastics Nilotinib

Antineoplastics Ponatinib Hydrochloride

Antineoplastics

Antineoplastics Lapatinib

Antineoplastics

Antineoplastics Axitinib

Antineoplastics Cabozantinib Updated nomenclature to include salt

Antineoplastics Cabozantinib S-Malate Updated nomenclature to include salt

Antineoplastics Lenvatinib New FDA Approved Drug, 2/13/15

Antineoplastics Pazopanib

Antineoplastics Regorafenib

Antineoplastics Sorafenib Tosylate

Antineoplastics Sunitinib Malate

Antineoplastics Vandetanib

Antineoplastics

Antineoplastics Idelalisib New FDA Approved Drug, 7/23/14

Antineoplastics

Antineoplastics Olaparib New FDA Approved Drug, 12/19/14

Antineoplastics

Antineoplastics Venetoclax New FDA Approved Drug, 4/11/16

Antineoplastics

Antineoplastics Belinostat New FDA Approved Drug, 7/3/14

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 11: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 11 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

516

517

518

519

520

521

522

523

524

525

526

527

528

529

530

531

532

533

534

535

536

537

538

539

540

541

542

543

544

545

546

547

548

549

550

551

552

553

554

555

556

557

558

559

560

561

562

563

564

Antineoplastics Panobinostat New FDA Approved Drug, 2/23/15

Antineoplastics Monoclonal Antibodies Monoclonal

Antibody/Antibody-Drug Conjugate

Nomenclature change; Renamed class to

reflect inclusion of Antibbody-Drug Conjugate

drugs

Antineoplastics Elotuzumab New FDA Approved Drug, 11/30/15

Antineoplastics

Antineoplastics Olaratumab New FDA Approved Drug, 10/19/2016

Antineoplastics

Antineoplastics Atezolizumab New FDA Approved Drug, 5/18/16

Antineoplastics Nivolumab New FDA Approved Drug, 12/22/14

Antineoplastics

Antineoplastics Rituximab

Antineoplastics Ofatumumab

Antineoplastics Retinoids

Antineoplastics Alitretinoin

Antineoplastics Bexarotene

Antineoplastics Tretinoin

Antineoplastics Treatment Adjuncts New class to reflect therapeutics

Antineoplastics Allopurinol Additional Classification; drug added to new

class

Antineoplastics Mesna Part D eligible drug (CY16 FRF v09.26.16)

Antineoplastics Rasburicase Part D eligible drug (CY16 FRF v09.26.16)

Antineoplastics Antineoplastics, Other

Antineoplastics Fludarabine

Antineoplastics Ixazomib New FDA Approved Drug, 11/20/15

Antineoplastics Leucovorin

Antineoplastics Mitoxantrone Hydrochloride

Antineoplastics Pegaspargase Part D eligibile drug (CY16 FRF v09.26.16)

Antineoplastics Tiperacil/Trifluridine New FDA Approved Drug, 09/22/15

Antineoplastics Vorinostat

Antiparasitics

Antiparasitics Anthelmintics

Antiparasitics Albendazole

Antiparasitics Ivermectin

Antiparasitics Mebendazole

Antiparasitics Praziquantel

Antiparasitics Antiprotozoals

Antiparasitics

Antiparasitics Miltefosine New FDA Approved Drug, 3/19/14

Antiparasitics

Antiparasitics Artemether/Lumefantrine

Antiparasitics Atovaquone/Proguanil

Hydrochloride

Antiparasitics Chloroquine Phosphate

Antiparasitics Hydroxychloroquine Sulfate

Antiparasitics Mefloquine Hydrochloride

Antiparasitics Primaquine Phosphate

Antiparasitics Pyrimethamine

Antiparasitics Quinine Sulfate

Antiparasitics

Antiparasitics Atovaquone

Antiparasitics Nitazoxanide

Antiparasitics Pentamidine Isethionate

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 12: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 12 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

565

566

567

568

569

570

571

572

573

574

575

576

577

578

579

580

581

582

583

584

585

586

587

588

589

590

591

592

593

594

595

596

597

598

599

600

601

602

603

604

605

606

607

608

609

610

611

612

613

614

Antiparasitics Pediculicides/Scabicides

Antiparasitics Benzyl alcohol

Antiparasitics Crotamiton

Antiparasitics Lindane

Antiparasitics Malathion

Antiparasitics Permethrin

Antiparasitics Spinosad

Antiparkinson Agents

Antiparkinson Agents Anticholinergics

Antiparkinson Agents Benztropine Mesylate

Antiparkinson Agents Diphenhydramine Hydrochloride

Antiparkinson Agents Trihexyphenidyl Hydrochloride

Antiparkinson Agents Dopamine Agonists

Antiparkinson Agents Apomorphine Hydrochloride

Antiparkinson Agents Bromocriptine Mesylate

Antiparkinson Agents Pramipexole Dihydrochloride

Monohydrate

Antiparkinson Agents Ropinirole Hydrochloride

Antiparkinson Agents Rotigotine

Antiparkinson Agents Dopamine Precursors/ L-Amino Acid

Decarboxylase Inhibitors

Antiparkinson Agents Carbidopa

Antiparkinson Agents Carbidopa/Levodopa

Antiparkinson Agents Monoamine Oxidase B (MAO-B) Inhibitors

Antiparkinson Agents Rasagiline Mesylate

Antiparkinson Agents Selegiline Hydrochloride

Antiparkinson Agents Antiparkinson Agents, Other

Antiparkinson Agents

Antiparkinson Agents Entacapone

Antiparkinson Agents Tolcapone

Antiparkinson Agents

Antiparkinson Agents Amantadine Hydrochloride

Antipsychotics

Antipsychotics 1st Generation/Typical

Antipsychotics Chlorpromazine Hydrochloride

Antipsychotics Fluphenazine Hydrochloride

Antipsychotics Haloperidol Lactate

Antipsychotics Loxapine Succinate

Antipsychotics Perphenazine

Antipsychotics Pimozide

Antipsychotics Prochlorperazine Edisylate

Antipsychotics Prochlorperazine Maleate

Antipsychotics Thioridazine Hydrochloride

Antipsychotics Thiothixene Hydrochloride

Antipsychotics Trifluoperazine Hydrochloride

Antipsychotics 2nd Generation/Atypical

Antipsychotics Aripiprazole

Antipsychotics Asenapine

Antipsychotics Brexipiprazole New FDA Approved Drug, 7/10/15

Antipsychotics Cariprazine New FDA Approved Drug, 9/17/15

Antipsychotics Iloperidone

Antipsychotics Lurasidone

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 13: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 13 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

615

616

617

618

619

620

621

622

623

624

625

626

627

628

629

630

631

632

633

634

635

636

637

638

639

640

641

642

643

644

645

646

647

648

649

650

651

652

653

654

655

656

657

658

659

660

661

662

Antipsychotics Olanzapine

Antipsychotics Pimavanserin New FDA Approved Drug, 4/29/16

Antipsychotics Quetiapine Fumarate

Antipsychotics Paliperidone

Antipsychotics Risperidone

Antipsychotics Ziprasidone Hydrochloride

Antipsychotics Ziprasidone Mesylate

Antipsychotics Treatment-Resistant

Antipsychotics Clozapine

Antispasticity Agents

Antispasticity Agents Baclofen

Antispasticity Agents Dantrolene Sodium

Antispasticity Agents Tizanidine Hydrochloride

Antivirals

Antivirals Anti-cytomegalovirus (CMV) Agents

Antivirals Cidofovir

Antivirals Foscarnet Sodium

Antivirals Ganciclovir Sodium

Antivirals Valganciclovir Hydrochloride

Antivirals Anti-hepatitis B (HBV) Agents

Antivirals Adefovir Dipivoxil

Antivirals Entecavir

Antivirals Lamivudine

Antivirals Ribavirin

Antivirals Telbivudine

Antivirals Tenofovir Disoproxil

Fumarate

Antivirals

Antivirals Interferon Alfa-2b,

Recombinant

Antivirals Interferon Alfa-2b/Ribavirin

Antivirals Interferon Alfa-n3

Antivirals Peginterferon Alfa-2a

Antivirals Peginterferon Alfa-2b

Anti-hepatitis C (HCV) Agents, Direct

Acting

New class to reflect therapeutics

Antivirals

Antivirals Boceprevir Discontinued by manufacturer

Antivirals Simeprevir

Antivirals Telaprevir Discontinued by manufacturer

Antivirals

Antivirals Daclatasvir New FDA Approved Drug, 7/24/15

Antivirals Sofosbuvir

Antivirals

Antivirals Elbasvir/Grazoprevir New FDA Approved Drug, 1/28/16

Antivirals Ledipasvir/Sofosbuvir New FDA Approved Drug, 10/10/14

Antivirals Ombitasvir/Paritaprevir/

Ritonavir/Dasabuvir

New FDA Approved Drug, 12/19/14

Antivirals Sofosbuvir/Velpatasvir New FDA Approved Drug, 6/28/16

Anti-hepatitis C (HCV) Agents Anti-

hepatitis C (HCV) Agents, Other

Nomenclature change; Renamed class to

reflect therapeutics

Ribavirin

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 14: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 14 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

663

664

665

666

667

668

669

670

671

672

673

674

675

676

677

678

679

680

681

682

683

684

685

686

687

688

689

690

691

692

693

694

695

696

697

698

699

700

701

702

703

704

Interferon Alfa-2b,

Recombinant

Interferon Alfa-2b/Ribavirin

Interferon Alfa-n3

Interferon Alfacon-1

Peginterferon Alfa-2a

Peginterferon Alfa-2b

Antivirals Antiherpetic Agents

Antivirals Acyclovir

Antivirals Famciclovir

Antivirals Foscarnet Sodium

Antivirals Idoxuridine

Antivirals Trifluridine

Antivirals Penciclovir Sodium

Antivirals Valacyclovir Hydrochloride

Antivirals Anti-HIV Agents, Non-nucleoside Reverse

Transcriptase Inhibitors (NNRTI)

Antivirals Delavirdine Mesylate

Antivirals Efavirenz

Antivirals Etravirine

Antivirals Nevirapine

Antivirals Rilpivirine

Antivirals Efavirenz/ Emtricitabine/

Tenofovir disoproxil fumarate

Antivirals Emtricitabine/ Rilpivirine /

Tenofovir disoproxil fumerate

Antivirals Anti-HIV Agents, Nucleoside and

Nucleotide Reverse Transcriptase

Inhibitors (NRTI)

Antivirals Abacavir Sulfate

Antivirals Abacavir/Lamivudine

Antivirals Abacavir/ Lamivudine/

Zidovudine

Antivirals Didanosine

Antivirals

Antivirals Emtricitabine

Antivirals Emtricitabine/Tenofovir Disoproxil

Fumarate

Antivirals Lamivudine

Antivirals Lamivudine/Zidovudine

Antivirals Stavudine

Antivirals Tenofovir Disoproxil

Fumarate

Antivirals Zidovudine

Antivirals Anti-HIV Agents, Protease Inhibitors

Antivirals Atazanavir Sulfate

Antivirals Atazanavir/ Cobicistat New FDA Approved Drug, 1/29/15

Antivirals Darunavir Ethanolate

Antivirals Darunavir/Cobicistat New FDA Approved Drug, 1/29/15

Antivirals Fosamprenavir Calcium

Antivirals Indinavir Sulfate

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 15: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 15 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

705

706

707

708

709

710

711

712

713

714

715

716

717

718

719

720

721

722

723

724

725

726

727

728

729

730

731

732

733

734

735

736

737

738

739

740

741

742

743

744

745

746

747

748

749

750

Antivirals Lopinavir/Ritonavir

Antivirals Nelfinavir Mesylate

Antivirals Ritonavir

Antivirals Saquinavir Mesylate

Antivirals Tipranavir

Antivirals Anti-HIV Agents, Integrase Inhibitors

(INSTI)

Antivirals Dolutegravir Sodium

Antivirals Elvitegravir/ Cobicistat/

Emtricitabine/ Tenofovir

disoproxil fumarate

Antivirals Elvitegravir/ Cobicistat/

Emtricitabine/ Tenofovir

alafenamide

New FDA Approved Drug, 11/5/15

Antivirals Raltegravir

Antivirals Anti-HIV Agents, Other

Antivirals Enfuvirtide

Antivirals Maraviroc

Antivirals Anti-influenza Agents

Antivirals Amantadine Hydrochloride

Antivirals Oseltamivir Phosphate

Antivirals Peramivir New FDA Approved Drug, 12/19/14

Antivirals Rimantadine Hydrochloride

Antivirals Zanamivir

Anxiolytics

Anxiolytics SSRIs/SNRIs (Selective Serotonin

Reuptake Inhibitors/ Serotonin and

Norepinephrine Reuptake Inhibitors)

Anxiolytics Duloxetine Hydrochloride

Anxiolytics Escitalopram Oxalate

Anxiolytics Paroxetine Hydrochloride

Anxiolytics Sertraline Hydrochloride

Anxiolytics Venlafaxine Hydrochloride

Anxiolytics Benzodiazepines

Anxiolytics Alprazolam

Anxiolytics Chlordiazepoxide

Anxiolytics Clonazepam

Anxiolytics Clorazepate Dipotassium

Anxiolytics Diazepam

Anxiolytics Lorazepam

Anxiolytics Oxazepam

Anxiolytics Anxiolytics, Other

Anxiolytics Buspirone Hydrochloride

Anxiolytics Doxepin Hydrochloride

Anxiolytics Hydroxyzine Hydrochloride

Anxiolytics Meprobamate

Bipolar Agents

Bipolar Agents Mood Stabilizers

Bipolar Agents Carbamazepine

Bipolar Agents Divalproex Sodium

Bipolar Agents Lamotrigine

Bipolar Agents Lithium Carbonate

Bipolar Agents Valproic Acid

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 16: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 16 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

751

752

753

754

755

756

757

758

759

760

761

762

763

764

765

766

767

768

769

770

771

772

773

774

775

776

777

778

779

780

781

782

783

784

785

786

787

788

789

790

791

792

793

794

795

796

797

798

799

800

801

802

803

804

Bipolar Agents Bipolar Agents, Other

Bipolar Agents Aripiprazole

Bipolar Agents Asenapine

Bipolar Agents Olanzapine

Bipolar Agents Quetiapine Fumarate

Bipolar Agents Risperidone

Bipolar Agents Ziprasidone Hydrochloride

Bipolar Agents Ziprasidone Mesylate

Blood Glucose Regulators

Blood Glucose Regulators Antidiabetic Agents

Blood Glucose Regulators

Blood Glucose Regulators Acarbose

Blood Glucose Regulators Miglitol

Blood Glucose Regulators

Blood Glucose Regulators Pramlintide Acetate

Blood Glucose Regulators

Blood Glucose Regulators Metformin Hydrochloride

Blood Glucose Regulators

Blood Glucose Regulators Colesevelam Hydrochloride

Blood Glucose Regulators

Blood Glucose Regulators Alogliptin

Blood Glucose Regulators Linagliptin

Blood Glucose Regulators Saxagliptin

Blood Glucose Regulators Sitagliptin Phosphate

Blood Glucose Regulators

Blood Glucose Regulators Bromocriptine Mesylate

Blood Glucose Regulators

Blood Glucose Regulators Albiglutide New FDA Approved Drug, 4/15/14

Dulaglutide New FDA Approved Drug, 9/18/14

Blood Glucose Regulators Exenatide

Blood Glucose Regulators Liraglutide

Blood Glucose Regulators Lixisenatide New FDA Approved Drug, 7/27/16

Blood Glucose Regulators

Blood Glucose Regulators Nateglinide

Blood Glucose Regulators Repaglinide

Blood Glucose Regulators

Blood Glucose Regulators Canagliflozin

Blood Glucose Regulators Dapagliflozin New FDA Approved Drug, 1/8/14

Blood Glucose Regulators Empagliflozin New FDA Approved Drug, 8/1/14

Blood Glucose Regulators

Blood Glucose Regulators Chlorpropamide

Blood Glucose Regulators Glimepiride

Blood Glucose Regulators Glipizide

Blood Glucose Regulators Glyburide

Blood Glucose Regulators Tolazamide

Blood Glucose Regulators Tolbutamide

Blood Glucose Regulators

Blood Glucose Regulators Pioglitazone Hydrochloride

Blood Glucose Regulators Rosiglitazone Maleate

Blood Glucose Regulators Glycemic Agents

Blood Glucose Regulators Diazoxide

Blood Glucose Regulators Diazoxide

Blood Glucose Regulators Glucagon

Blood Glucose Regulators Insulins

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 17: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 17 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

805

806

807

808

809

810

811

812

813

814

815

816

817

818

819

820

821

822

823

824

825

826

827

828

829

830

831

832

833

834

835

836

837

838

839

840

841

842

843

844

845

846

847

848

849

850

851

852

853

Blood Glucose Regulators

Blood Glucose Regulators Insulin Aspart

Blood Glucose Regulators Insulin Glulisine

Blood Glucose Regulators Insulin Lispro

Blood Glucose Regulators

Blood Glucose Regulators Insulin Human (Regular)

Blood Glucose Regulators

Blood Glucose Regulators Isophane Insulin (Human)

Blood Glucose Regulators

Blood Glucose Regulators Insulin Degludec New FDA Approved Drug, 9/25/15

Blood Glucose Regulators Insulin Detemir

Blood Glucose Regulators Insulin Glargine

Blood Glucose Regulators

Blood Glucose Regulators Insulin Aspart Rapid-acting/

Insulin Aspart Protamine

Blood Glucose Regulators Insulin Lispro Rapid-acting/

Insulin Lispro Protamine

Blood Glucose Regulators

Blood Glucose Regulators Insulin Human Regular/

Isophane Insulin

Blood Products/Modifiers/ Volume

Expanders

Blood Products Anticoagulants

Blood Products

Blood Products Dabigatran

Blood Products

Blood Products Apixaban

Blood Products Rivaroxaban

Blood Products Edoxaban New FDA Approved Drug, 1/8/15

Blood Products

Blood Products Fondaparinux Sodium

Blood Products

Blood Products

Blood Products Dalteparin Sodium

Blood Products Enoxaparin Sodium

Blood Products

Blood Products Vorapaxar New FDA Approved Drug, 5/8/14

Blood Products

Blood Products Warfarin Sodium

Blood Products Blood Formation Modifiers

Blood Products

Blood Products Azacitidine New FDA Approved Drug, 4/29/16

Blood Products

Blood Products Filgrastim

Blood Products Pegfilgrastim

Blood Products Sargramostim

Blood Products

Blood Products Darbepoetin Alfa

Blood Products Epoetin Alfa

Blood Products

Blood Products Anagrelide

Blood Products

Blood Products Eltrombopag Olamine

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 18: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 18 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

854

855

856

857

858

859

860

861

862

863

864

865

866

867

868

869

870

871

872

873

874

875

876

877

878

879

880

881

882

883

884

885

886

887

888

889

890

891

892

893

894

895

896

897

898

899

900

901

902

903

904

Blood Products Romiplostim

Blood Products

Blood Products Plerixafor

Blood Products Coagulants

Hemostasis Agents

Nomenclature change; Renamed class to

reflect therapeutics

Blood Products

Blood Products Tranexamic Acid

Blood Products Platelet Modifying Agents

Blood Products

Blood Products Clopidogrel Bisulfate

Blood Products Prasugrel

Blood Products Ticlopidine Hydrochloride

Blood Products Ticagrelor

Blood Products

Blood Products Dipyridamole

Blood Products Dipyridamole/ Aspirin

Blood Products

Blood Products Cilostazol

Cardiovascular Agents

Cardiovascular Agents Alpha-adrenergic Agonists

Cardiovascular Agents Clonidine Hydrochloride

Cardiovascular Agents Droxidopa New FDA Approved Drug, 2/18/14

Cardiovascular Agents Guanfacine Hydrochloride

Cardiovascular Agents Methyldopa

Cardiovascular Agents Methyldopate Hydrochloride

Cardiovascular Agents Midodrine Hydrochloride

Cardiovascular Agents Phenylephrine Hydrochloride

Cardiovascular Agents Alpha-adrenergic Blocking Agents

Cardiovascular Agents Doxazosin Mesylate

Cardiovascular Agents Phenoxybenzamine Hydrochloride

Cardiovascular Agents Prazosin Hydrochloride

Cardiovascular Agents Terazosin Hydrochloride

Cardiovascular Agents Angiotensin-converting Enzyme (ACE)

Inhibitors

Cardiovascular Agents Benazepril Hydrochloride

Cardiovascular Agents Captopril

Cardiovascular Agents Enalapril Maleate

Cardiovascular Agents Fosinopril Sodium

Cardiovascular Agents Lisinopril

Cardiovascular Agents Moexipril Hydrochloride

Cardiovascular Agents Perindopril Erbumine

Cardiovascular Agents Quinapril Hydrochloride

Cardiovascular Agents Ramipril

Cardiovascular Agents Trandolapril

Cardiovascular Agents Angiotensin II Receptor Antagonists

Cardiovascular Agents Azilsartan Medoxomil

Cardiovascular Agents Candesartan Cilexetil

Cardiovascular Agents Eprosartan Mesylate

Cardiovascular Agents Irbesartan

Cardiovascular Agents Losartan Potassium

Cardiovascular Agents Olmesartan Medoxomil

Cardiovascular Agents Telmisartan

Cardiovascular Agents Valsartan

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 19: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 19 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

905

906

907

908

909

910

911

912

913

914

915

916

917

918

919

920

921

922

923

924

925

926

927

928

929

930

931

932

933

934

935

936

937

938

939

940

941

942

943

944

945

946

947

948

949

950

951

952

953

954

955

956

Cardiovascular Agents Antiarrhythmics

Cardiovascular Agents Amiodarone Hydrochloride

Cardiovascular Agents Disopyramide Phosphate

Cardiovascular Agents Dofetilide

Cardiovascular Agents Dronedarone

Cardiovascular Agents Flecainide Acetate

Cardiovascular Agents Mexiletine Hydrochloride

Cardiovascular Agents Procainamide Hydrochloride

Cardiovascular Agents Propafenone Hydrochloride

Cardiovascular Agents Quinidine Hydrochloride

Cardiovascular Agents Sotalol Hydrochloride

Cardiovascular Agents Beta-adrenergic Blocking Agents

Cardiovascular Agents Acebutolol Hydrochloride

Cardiovascular Agents Atenolol

Cardiovascular Agents Betaxolol Hydrochloride

Cardiovascular Agents Bisoprolol Fumarate

Cardiovascular Agents Carvedilol Phosphate

Cardiovascular Agents Labetalol Hydrochloride

Cardiovascular Agents Metoprolol Succinate

Cardiovascular Agents Tartrate

Cardiovascular Agents Nadolol

Cardiovascular Agents Nebivolol

Cardiovascular Agents Penbutolol Sulfate Discontinued by manufacturer

Cardiovascular Agents Pindolol

Cardiovascular Agents Propranolol Hydrochloride

Cardiovascular Agents Timolol Maleate

Cardiovascular Agents Calcium Channel Blocking Agents

Cardiovascular Agents

Cardiovascular Agents Amlodipine

Cardiovascular Agents Felodipine

Cardiovascular Agents Isradipine

Cardiovascular Agents Nicardipine Hydrochloride

Cardiovascular Agents Nifedipine

Cardiovascular Agents Nimodipine

Cardiovascular Agents Nisoldipine

Cardiovascular Agents

Cardiovascular Agents Diltiazem Hydrochloride

Cardiovascular Agents Verapamil Hydrochloride

Cardiovascular Agents

Cardiovascular Agents Diuretics, Carbonic Anhydrase Inhibitors

Cardiovascular Agents Acetazolamide Sodium

Cardiovascular Agents Methazolamide

Cardiovascular Agents Diuretics, Loop

Cardiovascular Agents Bumetanide

Cardiovascular Agents Ethacrynate Sodium

Cardiovascular Agents Ethacrynic Acid

Cardiovascular Agents Furosemide

Cardiovascular Agents Torsemide

Cardiovascular Agents Diuretics, Potassium-sparing

Cardiovascular Agents Amiloride Hydrochloride

Cardiovascular Agents Eplerenone

Cardiovascular Agents Spironolactone

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 20: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 20 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

957

958

959

960

961

962

963

964

965

966

967

968

969

970

971

972

973

974

975

976

977

978

979

980

981

982

983

984

985

986

987

988

989

990

991

992

993

994

995

996

997

998

999

1000

1001

1002

1003

1004

1005

1006

Cardiovascular Agents Triamterene

Cardiovascular Agents Diuretics, Thiazide

Cardiovascular Agents Bendroflumethiazide

Cardiovascular Agents Chlorothiazide Sodium

Cardiovascular Agents Chlorthalidone

Cardiovascular Agents Hydrochlorothiazide

Cardiovascular Agents Indapamide

Cardiovascular Agents Methyclothiazide

Cardiovascular Agents Metolazone

Cardiovascular Agents Dyslipidemics, Fibric Acid Derivatives

Cardiovascular Agents Choline Fenofibrate

Cardiovascular Agents Fenofibrate

Cardiovascular Agents Fenofibric Acid

Cardiovascular Agents Gemfibrozil

Cardiovascular Agents Dyslipidemics, HMG CoA Reductase

Inhibitors

Cardiovascular Agents Atorvastatin Calcium

Cardiovascular Agents Fluvastatin Sodium

Cardiovascular Agents Lovastatin

Cardiovascular Agents Pitavastatin

Cardiovascular Agents Pravastatin Sodium

Cardiovascular Agents Rosuvastatin Calcium

Cardiovascular Agents Simvastatin

Cardiovascular Agents Dyslipidemics, Other

Cardiovascular Agents Cholestyramine

Cardiovascular Agents Colesevelam Hydrochloride

Cardiovascular Agents Colestipol Hydrochloride

Cardiovascular Agents Ezetimibe

Cardiovascular Agents Icosapent ethyl

Cardiovascular Agents Lomitapide Mesylate

Cardiovascular Agents Mipomersen Sodium

Cardiovascular Agents Niacin

Cardiovascular Agents Omega-3-acid Ethyl Esters

Cardiovascular Agents

Cardiovascular Agents Alirocumab New FDA Approved Drug, 7/24/15

Cardiovascular Agents Evolocumab New FDA Approved Drug, 8/27/15

Cardiovascular Agents Vasodilators, Direct-acting Arterial

Cardiovascular Agents Hydralazine Hydrochloride

Cardiovascular Agents Minoxidil

Cardiovascular Agents Vasodilators, Direct-acting Arterial/Venous

Cardiovascular Agents Isosorbide Dinitrate

Cardiovascular Agents Isosorbide Mononitrate

Cardiovascular Agents Nitroglycerin

Cardiovascular Agents Cardiovascular Agents, Other

Cardiovascular Agents Aliskiren

Cardiovascular Agents Digoxin

Cardiovascular Agents Ivabradine New FDA Approved Drug, 4/15/15

Cardiovascular Agents Pentoxifylline

Cardiovascular Agents Ranolazine

Cardiovascular Agents Sacubitril/Valsartan New FDA Approved Drug, 7/7/15

Central Nervous System Agents

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 21: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 21 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1007

1008

1009

1010

1011

1012

1013

1014

1015

1016

1017

1018

1019

1020

1021

1022

1023

1024

1025

1026

1027

1028

1029

1030

1031

1032

1033

1034

1035

1036

1037

1038

1039

1040

1041

1042

1043

1044

1045

1046

1047

1048

1049

1050

1051

1052

1053

1054

1055

Central Nervous System Agents Attention Deficit Hyperactivity Disorder

Agents, Amphetamines

Central Nervous System Agents Dextroamphetamine Sulfate

Central Nervous System Agents Dextroamphetamine/

Amphetamine

Mixed Salts

Central Nervous System Agents Lisdexamfetamine

Central Nervous System Agents Methamphetamine Hydrochloride

Central Nervous System Agents Attention Deficit Hyperactivity Disorder

Agents, Non-amphetamines

Central Nervous System Agents Atomoxetine Hydrochloride

Central Nervous System Agents Clonidine Hydrochloride

Central Nervous System Agents Dexmethylphenidate Hydrochloride

Central Nervous System Agents Guanfacine Hydrochloride

Central Nervous System Agents Methylphenidate Hydrochloride

Central Nervous System Agents Fibromyalgia Agents

Central Nervous System Agents Duloxetine Hydrochloride

Central Nervous System Agents Milnacipran

Central Nervous System Agents Pregabalin

Central Nervous System Agents Multiple Sclerosis Agents

Central Nervous System Agents

Central Nervous System Agents Interferon Beta-1a

Central Nervous System Agents Interferon Beta-1b

Central Nervous System Agents

Central Nervous System Agents Dalfampridine

Central Nervous System Agents

Central Nervous System Agents Teriflunomide

Central Nervous System Agents

Central Nervous System Agents Fingolimod

Central Nervous System Agents

Central Nervous System Agents Dimethyl fumarate

Central Nervous System Agents Glatiramer Acetate

Central Nervous System Agents Mitoxantrone Hydrochloride

Central Nervous System Agents Peginterferon Beta 1A New FDA Approved Drug, 8/15/14

Central Nervous System Agents Natalizumab

Central Nervous System Agents Daclizumab New FDA Approved Drug, 5/27/16

Central Nervous System Agents Central Nervous System, Other

Central Nervous System Agents Gabapentin enacarbil

Central Nervous System Agents

Central Nervous System Agents Tetrabenazine

Central Nervous System Agents Riluzole

Central Nervous System Agents Dextromethorphan/ Quinidine

Dental and Oral Agents

Dental and Oral Agents Cevimeline Hydrochloride

Dental and Oral Agents Chlorhexidine Gluconate

Dental and Oral Agents Doxycycline Hyclate

Dental and Oral Agents Minocycline Hydrochloride

Dental and Oral Agents Palifermin

Dental and Oral Agents Pilocarpine Hydrochloride

Dental and Oral Agents Prilocaine Hydrochloride

Dental and Oral Agents Triamcinolone Acetonide

Dermatological Agents

Dermatological Agents

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 22: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 22 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1056

1057

1058

1059

1060

1061

1062

1063

1064

1065

1066

1067

1068

1069

1070

1071

1072

1073

1074

1075

1076

1077

1078

1079

1080

1081

1082

1083

1084

1085

1086

1087

1088

1089

1090

1091

1092

1093

1094

1095

1096

1097

1098

1099

1100

1101

1102

1103

1104

1105

Dermatological Agents Isotretinoin

Dermatological Agents

Dermatological Agents Adapalene

Dermatological Agents Azelaic Acid

Dermatological Agents Benzoyl Peroxide

Dermatological Agents Dapsone

Dermatological Agents Tazarotene

Dermatological Agents

Dermatological Agents Doxycycline Calcium

Dermatological Agents Hyclate

Dermatological Agents

Dermatological Agents Doxepin Hydrochloride

Dermatological Agents

Dermatological Agents Pimecrolimus

Dermatological Agents Tacrolimus

Dermatological Agents

Dermatological Agents Podofilox

Dermatological Agents

Dermatological Agents Ammonium Lactate

Dermatological Agents

Dermatological Agents Imiquimod

Dermatological Agents Sinecatechins

Dermatological Agents

Dermatological Agents Selenium Sulfide

Dermatological Agents

Dermatological Agents Diclofenac Sodium

Dermatological Agents Fluorouracil

Dermatological Agents Imiquimod

Dermatological Agents Ingenol mebutate

Dermatological Agents

Dermatological Agents Methoxsalen

Dermatological Agents

Dermatological Agents Acitretin

Dermatological Agents Calcitriol

Dermatological Agents Ustekinumab

Dermatological Agents Secukinumab New FDA Approved Drug, 1/21/15

Dermatological Agents Ixekizumab New FDA Approved Drug, 3/22/16

Dermatological Agents

Dermatological Agents Calcipotriene

Dermatological Agents

Dermatological Agents Becaplermin

Dermatological Agents Collagenase

Dermatological Agents

Dermatological Agents Brimonidine Tartrate

Therapeutic Nutrients/ Minerals/

Electrolytes Electrolytes/Minerals/

Metals/ Vitamins

Nomenclature change; Renamed category to

reflect therapeutics. Moved according to

alphabetization.

Electrolytes Electrolyte/Mineral Modifiers

Electrolyte/Mineral/Metal Modifiers

Nomenclature change; Renamed class to

reflect therapeutics

Electrolytes

Electrolytes Deferasirox

Electrolytes Deferiprone

Electrolytes

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 23: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 23 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1106

1107

1108

1109

1110

1111

1112

1113

1114

1115

1116

1117

1118

1119

1120

1121

1122

1123

1124

1125

1126

1127

1128

1129

1130

1131

1132

1133

1134

1135

1136

1137

1138

1139

1140

1141

1142

1143

1144

1145

1146

1147

1148

1149

Patiromer Sorbitex Calcium New FDA Approved Drug, 10/21/15

Electrolytes Penicillamine

Electrolytes Sodium Polystyrene

Sulfonate

Electrolytes Succimer

Electrolytes Tolvaptan

Electrolytes Trientine Hydrochloride

Electrolytes

Electrolytes Electrolyte/Mineral Replacement

Electrolytes Ammonium Chloride

Electrolytes Carglumic Acid

Electrolytes Chromic Chloride

Electrolytes Citric Acid/ Potassium

Citrate/ Sodium Citrate

Electrolytes Fluoride Sodium

Electrolytes Stannous

Electrolytes Magnesium Chloride

Electrolytes Sulfate

Electrolytes Manganese Chloride

Electrolytes Potassium Acetate

Electrolytes Bicarbonate

Electrolytes Chloride

Electrolytes Citrate

Electrolytes Gluconate

Electrolytes Phosphates

Electrolytes Potassium Bicarbonate/

Potassium Citrate

Electrolytes Potassium Citrate/ Citric Acid

Electrolytes Potassium Citrate/ Sodium

Citrate

Electrolytes Potassium Gluconate/

Potassium Chloride

Electrolytes Potassium Gluconate/

Potassium Citrate

Electrolytes Potassium Phosphate/

Sodium Phosphate

Electrolytes Selenium

Electrolytes Sodium Acetate

Electrolytes Sodium Bicarbonate

Electrolytes Sodium Lactate

Electrolytes Sodium Chloride

Electrolytes Sodium Ferric Gluconate

Complex

Electrolytes Sodium Phosphates

Electrolytes Phosphate Binders Class moved from USP Category

Genitourinary Agents

Electrolytes Calcium Acetate

Electrolytes Ferric Citrate New FDA Approved Drug, 9/5/14

Electrolytes Lanthanum Carbonate

Electrolytes Sevelamer Hydrochloride

Electrolytes Sucroferric Oxyhydroxide

Electrolytes Vitamins

Prenatal Part D eligibile drug (CY16 FRF v09.26.16)

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 24: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 24 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1150

1151

1152

1153

1154

1155

1156

1157

1158

1159

1160

1161

1162

1163

1164

1165

1166

1167

1168

1169

1170

1171

1172

1173

1174

1175

1176

1177

1178

1179

1180

1181

1182

1183

1184

1185

1186

1187

1188

1189

1190

1191

1192

1193

1194

1195

1196

Gastrointestinal Agents

Gastrointestinal Agents Antispasmodics, Gastrointestinal

Gastrointestinal Agents Atropine Sulfate

Gastrointestinal Agents Dicyclomine Hydrochloride

Gastrointestinal Agents Glycopyrrolate

Gastrointestinal Agents Mepenzolate Bromide

Gastrointestinal Agents Methscopolamine Bromide

Gastrointestinal Agents Scopolamine

Gastrointestinal Agents Histamine2 (H2) Receptor Antagonists

Gastrointestinal Agents Cimetidine Hydrochloride

Gastrointestinal Agents Famotidine

Gastrointestinal Agents Nizatidine

Gastrointestinal Agents Ranitidine Hydrochloride

Gastrointestinal Agents Irritable Bowel Syndrome Agents

Gastrointestinal Agents

Gastrointestinal Agents Eluxadoline New FDA Approved Drug, 5/27/15

Gastrointestinal Agents Rifaximin New FDA Approved Drug, 3/24/10

Gastrointestinal Agents Alosetron Hydrochloride

Gastrointestinal Agents

Gastrointestinal Agents Linaclotide

Gastrointestinal Agents Lubiprostone

Gastrointestinal Agents Laxatives

Gastrointestinal Agents Lactulose

Gastrointestinal Agents Polyethylene Glycol 3350 NF

Gastrointestinal Agents Sodium picosulfate/

magnesium oxide/ citric acid

Gastrointestinal Agents Protectants

Gastrointestinal Agents Misoprostol

Gastrointestinal Agents Sucralfate

Gastrointestinal Agents Proton Pump Inhibitors

Gastrointestinal Agents Dexlansoprazole

Gastrointestinal Agents Esomeprazole Magnesium

Gastrointestinal Agents Lansoprazole

Gastrointestinal Agents Omeprazole

Gastrointestinal Agents Pantoprazole Sodium

Gastrointestinal Agents Rabeprazole Sodium

Gastrointestinal Agents Gastrointestinal Agents, Other

Gastrointestinal Agents Alvimopan

Gastrointestinal Agents Crofelemer

Gastrointestinal Agents Difenoxin Hydrochloride/

Atropine Sulfate

Gastrointestinal Agents Diphenoxylate Hydrochloride/

Atropine Sulfate

Gastrointestinal Agents Loperamide Hydrochloride

Gastrointestinal Agents Methylnaltrexone

Gastrointestinal Agents Metoclopramide

Gastrointestinal Agents Metreleptin New FDA Approved Drug, 2/24/14

Gastrointestinal Agents Rifaximin

Gastrointestinal Agents Ursodiol

Gastrointestinal Agents Naloxegol New FDA Approved Drug, 9/16/14

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 25: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 25 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1197

1198

1199

1200

1201

1202

1203

1204

1205

1206

1207

1208

1209

1210

1211

1212

1213

1214

1215

1216

1217

1218

1219

1220

1221

1222

1223

1224

1225

1226

1227

1228

1229

1230

1231

1232

1233

1234

1235

1236

1237

1238

1239

1240

1241

1242

1243

1244

1245

Gastrointestinal Agents

Gastrointestinal Agents Glutamine

Gastrointestinal Agents Somatropin

Enzyme Replacement/Modifiers

Genetic or Enzyme Disorder:

Replacement, Modifiers, Treatment

Nomenclature change; Renamed to reflect

therapeutics. Moved according to

alphabetization.

Genetic or Enzyme Alpha-1 Protinease Inhibitor,

Human

Reclassification; drug moved from the class,

"Respiratory Tract Agents, Other," due to

therapeutics.

Genetic or Enzyme

Genetic or Enzyme Cholic Acid New FDA Approved drug, 3/17/15

Genetic or Enzyme

Genetic or Enzyme

Genetic or Enzyme Cysteamine Bitartrate

Genetic or Enzyme

Genetic or Enzyme Eteplirsen New FDA Approved Drug, 9/19/16

Genetic or Enzyme

Genetic or Enzyme Agalsidase Beta

Genetic or Enzyme

Genetic or Enzyme Alglucerase

Genetic or Enzyme Imiglucerase

Genetic or Enzyme Taliglucerase alfa

Genetic or Enzyme Velaglucerase alfa

Genetic or Enzyme

Genetic or Enzyme Eliglustat New FDA Approved Drug, 8/19/14

Genetic or Enzyme Miglustat

Genetic or Enzyme

Genetic or Enzyme Nitisinone

Genetic or Enzyme

Genetic or Enzyme Betaine Anhydrous

Genetic or Enzyme

Genetic or Enzyme Idursulfase

Genetic or Enzyme

Genetic or Enzyme Asfotase Alfa New FDA Approved Drug,10/23/15

Genetic or Enzyme

Genetic or Enzyme Sebelipase Alfa New FDA Approved Drug, 12/8/15

Genetic or Enzyme

Genetic or Enzyme Galsulfase

Genetic or Enzyme Laronidase

Genetic or Enzyme Elosulfase Alfa New FDA Approved Drug, 2/14/14

Genetic or Enzyme

Genetic or Enzyme Pancrelipase

Genetic or Enzyme

Genetic or Enzyme Sapropterin

Genetic or Enzyme

Genetic or Enzyme Pegademase Bovine

Genetic or Enzyme

Genetic or Enzyme Sacrosidase

Genetic or Enzyme

Genetic or Enzyme Sodium Phenylbutyrate

Genetic or Enzyme Glycerol Phenylbutyrate

Genetic or Enzyme Obeticholic Acid New FDA Approved Drug, 5/27/16

Genitourinary Agents

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 26: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 26 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1246

1247

1248

1249

1250

1251

1252

1253

1254

1255

1256

1257

1258

1259

1260

1261

1262

1263

1264

1265

1266

1267

1268

1269

1270

1271

1272

1273

1274

1275

1276

1277

1278

1279

1280

1281

1282

1283

1284

1285

1286

1287

1288

1289

1290

1291

1292

Genitourinary Agents Antispasmodics, Urinary

Genitourinary Agents

Genitourinary Agents Mirabegron

Genitourinary Agents

Genitourinary Agents Darifenacin Hydrobromide

Genitourinary Agents Fesoterodine Fumarate

Genitourinary Agents Flavoxate Hydrochloride

Genitourinary Agents Oxybutynin Chloride

Genitourinary Agents Solifenacin Succinate

Genitourinary Agents Tolterodine Tartrate

Genitourinary Agents Trospium Chloride

Genitourinary Agents Benign Prostatic Hypertrophy Agents

Genitourinary Agents

Genitourinary Agents Alfuzosin Hydrochloride

Genitourinary Agents Doxazosin Mesylate

Genitourinary Agents Prazosin Hydrochloride

Genitourinary Agents Silodosin

Genitourinary Agents Tamsulosin Hydrochloride

Genitourinary Agents Terazosin Hydrochloride

Genitourinary Agents

Genitourinary Agents Dutasteride

Genitourinary Agents Finasteride

Genitourinary Agents

Genitourinary Agents Tadalafil

Genitourinary Agents Phosphate Binders Reclassification; class moved to the category,

Electrolytes/Minerals/Heavy Metals/

Vitamins."

Genitourinary Agents Calcium Acetate

Genitourinary Agents Lanthanum Carbonate

Genitourinary Agents Sevelamer Hydrochloride

Genitourinary Agents Sucroferric Oxyhydroxide

Genitourinary Agents Genitourinary Agents, Other

Genitourinary Agents Bethanechol

Genitourinary Agents Pencillamine

Genitourinary Agents Pentosan Polysulfate

Hormonal Agents, Stimulant/

Replacement/ Modifying (Adrenal)

Hormonal Agents

Hormonal Agents Corticotropin

Hormonal Agents

Hormonal Agents Betamethasone Sodium

Phosphate

Hormonal Agents Budesonide

Hormonal Agents Cortisone Acetate

Hormonal Agents Dexamethasone Acetate

Hormonal Agents Dexamethasone Sodium

Phosphate

Hormonal Agents Hydrocortisone Acetate

Hormonal Agents Hydrocortisone Sodium Succinate

Hormonal Agents Methylprednisolone Acetate

Hormonal Agents Methylprednisolone Sodium Succinate

Hormonal Agents Prednisolone Acetate

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 27: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 27 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1293

1294

1295

1296

1297

1298

1299

1300

1301

1302

1303

1304

1305

1306

1307

1308

1309

1310

1311

1312

1313

1314

1315

1316

1317

1318

1319

1320

1321

1322

1323

1324

1325

1326

1327

1328

1329

1330

1331

1332

1333

1334

1335

1336

1337

1338

1339

1340

1341

Hormonal Agents Prednisolone Sodium

Phosphate

Hormonal Agents Prednisone

Hormonal Agents Triamcinolone Acetonide

Hormonal Agents Triamcinolone Diacetate

Hormonal Agents Triamcinolone Hexacetonide

Hormonal Agents

Hormonal Agents Alclometasone Dipropionate

Hormonal Agents Clocortolone Pivalate

Hormonal Agents Desonide

Hormonal Agents Dexamethasone Sodium

Phosphate

Hormonal Agents Hydrocortisone

Hormonal Agents

Hormonal Agents Betamethasone Valerate

Hormonal Agents Desoximetasone

Hormonal Agents Fluocinolone Acetonide

Hormonal Agents Flurandrenolide

Hormonal Agents Fluticasone Propionate

Hormonal Agents Hydrocortisone Butyrate

Hormonal Agents Probutate

Hormonal Agents Valerate

Hormonal Agents Mometasone Furoate

Hormonal Agents Prednicarbate

Hormonal Agents Triamcinolone Acetonide

Hormonal Agents

Hormonal Agents Amcinonide

Hormonal Agents Betamethasone Dipropionate

Hormonal Agents Desoximetasone

Hormonal Agents Diflorasone Diacetate

Hormonal Agents Fluocinolone Acetonide

Hormonal Agents Fluocinonide

Hormonal Agents Halcinonide

Hormonal Agents Triamcinolone Acetonide

Hormonal Agents

Hormonal Agents Betamethasone Dipropionate

Hormonal Agents Clobetasol Propionate

Hormonal Agents Diflorasone Diacetate

Hormonal Agents Halobetasol Propionate

Hormonal Agents

Hormonal Agents Fludrocortisone Acetate

Hormonal Agents,

Stimulant/Replacement/ Modifying

(Pituitary)

Hormonal Agents

Hormonal Agents Chorionic Gonadotropin

Hormonal Agents

Hormonal Agents Somatropin, Recombinant

Hormonal Agents Tesamorelin

Hormonal Agents

Hormonal Agents Mecasermin Rinfabate

Hormonal Agents

Hormonal Agents Desmopressin Acetate

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 28: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 28 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1342

1343

1344

1345

1346

1347

1348

1349

1350

1351

1352

1353

1354

1355

1356

1357

1358

1359

1360

1361

1362

1363

1364

1365

1366

1367

1368

1369

1370

1371

1372

1373

1374

1375

1376

1377

1378

1379

1380

1381

1382

1383

1384

Hormonal Agents, Stimulant/

Replacement/ Modifying

(Prostaglandins)

Hormonal Agents Alprostadil

Hormonal Agents Carboprost Tromethamine

Hormonal Agents Misoprostol

Hormonal Agents, Stimulant/

Replacement/ Modifying (Sex

Hormones/ Modifiers)

Hormonal Agents Anabolic Steroids

Hormonal Agents Oxandrolone

Hormonal Agents Androgens

Hormonal Agents Danazol

Hormonal Agents Fluoxymesterone

Hormonal Agents Methyltestosterone

Hormonal Agents Testosterone Cypionate

Hormonal Agents Testosterone Enanthate

Hormonal Agents Testosterone Propionate

Hormonal Agents Estrogens

Hormonal Agents Estradiol Acetate

Hormonal Agents Estradiol Cypionate

Hormonal Agents Estradiol Hemihydrate

Hormonal Agents Estradiol Valerate

Hormonal Agents Estrogens, Conjugated

Hormonal Agents Estrogens, Conjugated

Synthetic

Hormonal Agents Estrogens, Esterified

Hormonal Agents Estrone Discontinued by manufacturer

Hormonal Agents Estropipate

Hormonal Agents Ethinyl Estradiol

Hormonal Agents Progesterone Agonists/Antagonists

Hormonal Agents Ulipristal

Hormonal Agents Progestins

Hormonal Agents Levonorgestrel

Hormonal Agents Medroxyprogesterone Acetate

Hormonal Agents Megestrol Acetate

Hormonal Agents Norethindrone Acetate

Hormonal Agents Norgestrel

Hormonal Agents Progesterone

Hormonal Agents Selective Estrogen Receptor Modifying

Agents

Hormonal Agents Raloxifene Hydrochloride

Hormonal Agents Ospemifene

Hormonal Agents Bazedoxifene/ conjugated

estrogens

Hormonal Agents,

Stimulant/Replacement/ Modifying

(Thyroid)

Hormonal Agents Levothyroxine Sodium

Hormonal Agents Liothyronine Sodium

Hormonal Agents Liotrix

Hormonal Agents, Suppressant

(Adrenal)

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 29: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 29 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1385

1386

1387

1388

1389

1390

1391

1392

1393

1394

1395

1396

1397

1398

1399

1400

1401

1402

1403

1404

1405

1406

1407

1408

1409

1410

1411

1412

1413

1414

1415

1416

1417

1418

1419

1420

1421

1422

1423

1424

1425

1426

1427

1428

1429

1430

1431

Hormonal Agents Mitotane

Hormonal Agents, Suppressant

(Parathyroid)

Category removed to reflect therapeutics

Hormonal Agents Cinacalcet Hydrochloride Reclassification; drug moved to USP

Category, "Metabolic Bone Disease Agents."

Hormonal Agents, Suppressant

(Pituitary)

Hormonal Agents

Hormonal Agents Bromocriptine Mesylate

Hormonal Agents Cabergoline

Hormonal Agents

Hormonal Agents Leuprolide Acetate

Hormonal Agents Nafarelin Acetate

Hormonal Agents Triptorelin Pamoate

Hormonal Agents

Hormonal Agents Degarelix

Hormonal Agents

Hormonal Agents Pegvisomant

Hormonal Agents

Hormonal Agents Lanreotide

Hormonal Agents Octreotide

Hormonal Agents Pasireotide

Hormonal Agents, Suppressant

(Thyroid)

Hormonal Agents Antithyroid Agents

Hormonal Agents Methimazole

Hormonal Agents Propylthiouracil

Immunological Agents

Immunological Agents Angioedema (HAE) Agents Angioedema

Agents

Nomenclature Change; removed parenthetical

Immunological Agents

Immunological Agents Icatibant Acetate

Immunological Agents

Immunological Agents C1 esterase inhibitor

(human)

Immunological Agents Immune Suppressants

Immunological Agents

Immunological Agents Mycophenolic Acid

Immunological Agents

Immunological Agents Tacrolimus

Immunological Agents Cyclosporine

Immunological Agents

Immunological Agents Tofacitinib

Immunological Agents

Immunological Agents Sirolimus

Immunological Agents

Immunological Agents 6- Mercaptopurine

Immunological Agents Abatacept

Immunological Agents Anakinra

Immunological Agents Everolimus

Immunological Agents Methotrexate Sodium

Immunological Agents Penicillamine

Immunological Agents Pimecrolimus

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 30: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 30 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1432

1433

1434

1435

1436

1437

1438

1439

1440

1441

1442

1443

1444

1445

1446

1447

1448

1449

1450

1451

1452

1453

1454

1455

1456

1457

1458

1459

1460

1461

1462

1463

1464

1465

1466

1467

1468

Immunological Agents

Immunological Agents

Immunological Agents Azathioprine

Immunological Agents

Immunological Agents Adalimumab

Immunological Agents Certolizumab Pegol

Immunological Agents Etanercept

Immunological Agents Golimumab

Immunological Agents Infliximab

Immunological Agents Immunizing Agents, Passive

Immunological Agents

Immunological Agents Anti-thymocyte Globulin

Immunological Agents Immune Globulin

Intramuscular (Human)

Immunological Agents Immune Globulin Intravenous

(Human)

Immunological Agents Immunomodulators

Immunological Agents

Immunological Agents Belimumab

Immunological Agents

Immunological Agents Interferon Gamma-1b,

Recombinant

Immunological Agents

Immunological Agents Canakinumab

Immunological Agents Rilonacept

Immunological Agents Siltuximab New FDA Approved Drug, 4/23/14

Immunological Agents Tocilizumab

Immunological Agents

Immunological Agents Auranofin

Immunological Agents Apremilast New FDA Approved Drug, 9/23/14

Immunological Agents Leflunomide

Immunological Agents Natalizumab

Immunological Agents Omalizumab Part D eligible drug (CY16 FRF v09.26.16)

Immunological Agents Vedolizumab New FDA Approved Drug, 5/20/14

Immunological Agents Vaccines

Immunological Agents

Immunological Agents Diphtheria and Tetanus

Toxoids Adsorbed (DT)

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed

(DTaP)

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed,

Hepatitis B (Recombinant)

and Inactivated Poliovirus

Vaccine

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Absorbed and

Inactivated Poliovirus (DTaP-

IPV) Vaccine

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 31: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 31 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1469

1470

1471

1472

1473

1474

1475

1476

1477

1478

1479

1480

1481

1482

1483

1484

1485

1486

1487

1488

1489

Immunological Agents Tetanus and Diphtheria

Toxoids Adsorbed for Adult

Use (Td)

Immunological Agents Tetanus Toxoid, Reduced

Diphtheria Toxoid and

Acellular Pertussis Vaccine,

Adsorbed (Tdap)

Immunological Agents

Immunological Agents Haemophilus B Conjugate

Vaccine

Immunological Agents Haemophilus B Conjugate

Vaccine and Hepatitis B

Vaccine (Recombinant)

Immunological Agents

Immunological Agents Hepatitis A Vaccine

Inactivated

Immunological Agents Hepatitis A Virus Vaccine

Inactivated and Hepatitis B

Virus Vaccine Recombinant

Immunological Agents

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed,

Hepatitis B (Recombinant)

and Inactivated Poliovirus

Vaccine

Immunological Agents Haemophilus B Conjugate

Vaccine and Hepatitis B

Vaccine (Recombinant)

Immunological Agents Hepatitis B Virus Vaccine

Recombinant

Immunological Agents

Immunological Agents Japanese Encephalitis Virus

Vaccine Inactivated

Immunological Agents

Immunological Agents Measles Virus Vaccine Live

Immunological Agents Measles, Mumps, and

Rubella Virus Vaccine Live

Immunological Agents Measles, Mumps, Rubella,

and Varicella Virus Vaccine

Live

Immunological Agents

Immunological Agents Meningococcal

Oligosaccharide Diphtheria

CRM197 Conjugate Vaccine

Immunological Agents Meningococcal

Polysaccharide Vaccine

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 32: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 32 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1490

1491

1492

1493

1494

1495

1496

1497

1498

1499

1500

1501

1502

1503

1504

1505

1506

1507

Immunological Agents Meningococcal

Polysaccharide Diphtheria

Toxoid Conjugate Vaccine

Immunological Agents

Immunological Agents Measles, Mumps, and

Rubella Virus Vaccine Live

Immunological Agents Measles, Mumps, Rubella,

and Varicella Virus Vaccine

Live

Immunological Agents

Immunological Agents Human Papillomavirus

Bivalent (type 16 and 18)

Vaccine Recombinant

Immunological Agents Human Papillomavirus

Quadrivalent (types 6, 11, 16

and 18) Vaccine

Recombinant

Immunological Agents

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed

(DTaP)

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed,

Hepatitis B (Recombinant)

and Inactivated Poliovirus

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Absorbed and

Inactivated Poliovirus (DTaP-

IPV) Vaccine

Immunological Agents Tetanus Toxoid, Reduced

Diphtheria Toxoid, and

Acellular Pertussis Vaccine,

Adsorbed (Tdap)

Immunological Agents

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Absorbed and

Inactivated Poliovirus (DTaP-

IPV) Vaccine

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed,

Hepatitis B (Recombinant)

and Inactivated Poliovirus

Immunological Agents Poliovirus Vaccine

Inactivated

Immunological Agents

Immunological Agents Rabies Vaccine

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 33: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 33 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1508

1509

1510

1511

1512

1513

1514

1515

1516

1517

1518

1519

1520

1521

1522

1523

1524

1525

1526

1527

1528

1529

1530

1531

1532

1533

1534

1535

Immunological Agents

Immunological Agents Rotavirus Vaccine Live

Immunological Agents

Immunological Agents Measles, Mumps, and

Rubella Virus Vaccine Live

Immunological Agents Measles, Mumps, Rubella,

and Varicella Virus Vaccine

Live

Immunological Agents Rubella Virus Vaccine

Immunological Agents

Immunological Agents Diphtheria and Tetanus

Toxoids Adsorbed (DT)

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed

(DTaP)

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Vaccine Adsorbed,

Hepatitis B (Recombinant)

and Inactivated Poliovirus

Vaccine

Immunological Agents Diphtheria and Tetanus

Toxoids and Acellular

Pertussis Absorbed and

Inactivated Poliovirus (DTaP-

IPV) Vaccine

Immunological Agents Tetanus and Diphtheria

Toxoids Adsorbed for Adult

Use (Td)

Immunological Agents Tetanus Toxoid

Immunological Agents Tetanus Toxoid Adsorbed

Immunological Agents Tetanus Toxoid, Reduced

Diphtheria Toxoid, and

Acellular Pertussis Vaccine,

Adsorbed (Tdap)

Immunological Agents

Immunological Agents Typhoid Vaccine Live Oral

Immunological Agents Typhoid Vi Polysaccharide

Vaccine

Immunological Agents

Immunological Agents Measles, Mumps, Rubella,

and Varicella Virus Vaccine

Live

Immunological Agents Meningococcal Group B

Vaccine

New FDA Approved Drug, 2/19/10

Immunological Agents Varicella Virus Vaccine

Immunological Agents

Immunological Agents Yellow Fever Vaccine

Immunological Agents

Immunological Agents Zoster Virus Vaccine Live

Inflammatory Bowel Disease Agents

Glucocorticoids

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 34: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 34 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1536

1537

1538

1539

1540

1541

1542

1543

1544

1545

1546

1547

1548

1549

1550

1551

1552

1553

1554

1555

1556

1557

1558

1559

1560

1561

1562

1563

1564

1565

1566

1567

1568

1569

1570

1571

1572

1573

1574

1575

1576

1577

1578

1579

1580

1581

1582

1583

Betamethasone

Budesonide

Cortisone Acetate

Dexamethasone Acetate

Dexamethasone Sodium

Phosphate

Hydrocortisone Sodium Succinate

Methylprednisolone Acetate

Methylprednisolone Sodium Succinate

Prednisolone Acetate

Prednisolone Sodium Succinate

Prednisone

Triamcinolone Acetonide

Triamcinolone Diacetate

Aminosalicylates

Balsalazide Disodium

Mesalamine

Olsalazine Sodium

Sulfonamides

Sulfasalazine

Metabolic Bone Disease Agents

Metabolic Bone Disease Agents

Metabolic Bone Disease Agents Alendronate Sodium

Metabolic Bone Disease Agents Etidronate Disodium

Metabolic Bone Disease Agents Ibandronate Sodium

Metabolic Bone Disease Agents Risedronate Sodium

Metabolic Bone Disease Agents Tiludronate Disodium Discontinued by manufacturer

Metabolic Bone Disease Agents

Metabolic Bone Disease Agents Ibandronate Sodium

Metabolic Bone Disease Agents Pamidronate Disodium

Metabolic Bone Disease Agents Zoledronic Acid

Metabolic Bone Disease Agents

Metabolic Bone Disease Agents Calcitonin, Salmon

Metabolic Bone Disease Agents

Metabolic Bone Disease Agents Teriparatide

Metabolic Bone Disease Agents

Metabolic Bone Disease Agents Denosumab

Metabolic Bone Disease Agents

Metabolic Bone Disease Agents Calcifediol New FDA Approved Drug, 6/17/16

Metabolic Bone Disease Agents Calcitriol

Metabolic Bone Disease Agents Cinacalcet Reclassification; drug moved from Hormonal

Agents, Parathyroid category due to

therapeutics

Metabolic Bone Disease Agents Doxercalciferol

Parathyroid Hormone New FDA Approved Drug, 1/23/15

Metabolic Bone Disease Agents Paricalcitol

Ophthalmic Agents

Ophthalmic Agents Ophthalmic Anti-allergy Agents

Ophthalmic Agents Azelastine Hydrochloride

Ophthalmic Agents Bepotastine

Ophthalmic Agents Cromolyn Sodium

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 35: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 35 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1584

1585

1586

1587

1588

1589

1590

1591

1592

1593

1594

1595

1596

1597

1598

1599

1600

1601

1602

1603

1604

1605

1606

1607

1608

1609

1610

1611

1612

1613

1614

1615

1616

1617

1618

1619

1620

1621

1622

1623

1624

1625

1626

1627

1628

1629

1630

1631

1632

1633

1634

1635

Ophthalmic Agents Emedastine Difumarate

Ophthalmic Agents Epinastine Hydrochloride

Ophthalmic Agents Lodoxamide Tromethamine

Ophthalmic Agents Nedocromil Sodium

Ophthalmic Agents Olopatadine Hydrochloride

Ophthalmic Agents Ophthalmic Antiglaucoma Agents

Ophthalmic Agents

Ophthalmic Agents Apraclonidine Hydrochloride

Ophthalmic Agents Brimonidine Tartrate

Ophthalmic Agents

Ophthalmic Agents Betaxolol Hydrochloride

Ophthalmic Agents Carteolol Hydrochloride

Ophthalmic Agents Levobunolol Hydrochloride

Ophthalmic Agents Metipranolol Hydrochloride

Ophthalmic Agents Timolol Hemihydrate

Ophthalmic Agents Timolol Maleate

Ophthalmic Agents

Ophthalmic Agents Acetazolamide

Ophthalmic Agents Brinzolamide

Ophthalmic Agents Dorzolamide Hydrochloride

Ophthalmic Agents Methazolamide

Ophthalmic Agents

Ophthalmic Agents Echothiophate Iodide

Ophthalmic Agents Pilocarpine Hydrochloride

Ophthalmic Agents Nitrate

Ophthalmic Agents Ophthalmic Anti-inflammatories

Ophthalmic Agents

Ophthalmic Agents Dexamethasone

Ophthalmic Agents Difluprednate

Ophthalmic Agents Fluorometholone Acetate

Ophthalmic Agents Loteprednol Etabonate

Ophthalmic Agents Prednisolone Acetate

Ophthalmic Agents Sodium

Phosphate

Ophthalmic Agents Rimexolone

Ophthalmic Agents

Ophthalmic Agents Bromfenac Sodium

Ophthalmic Agents Diclofenac Sodium

Ophthalmic Agents Flurbiprofen Sodium

Ophthalmic Agents Ketorolac Tromethamine

Ophthalmic Agents Nepafenac

Ophthalmic Agents Ophthalmic Prostaglandin and Prostamide

Analogs

Ophthalmic Agents Bimatoprost

Ophthalmic Agents Latanoprost

Ophthalmic Agents Tafluprost

Ophthalmic Agents Travoprost

Ophthalmic Agents Ophthalmic Agents, Other

Ophthalmic Agents Hydroxypropyl Cellulose

Ophthalmic Agents Naphazoline Hydrochloride Removed due to OTC status

Ophthalmic Agents Lifitegrast New FDA Approved Drug, 7/11/16

Ophthalmic Agents

Ophthalmic Agents Cyclosporine

Otic Agents

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 36: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 36 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1636

1637

1638

1639

1640

1641

1642

1643

1644

1645

1646

1647

1648

1649

1650

1651

1652

1653

1654

1655

1656

1657

1658

1659

1660

1661

1662

1663

1664

1665

1666

1667

1668

1669

1670

1671

1672

1673

1674

1675

1676

1677

1678

1679

1680

1681

Otic Agents

Otic Agents Fluocinolone Acetonide

Respiratory Tract/ Pulmonary Agents

Antihistamines

Azelastine Hydrochloride

Cetirizine Hydrochloride

Desloratadine

Levocetirizine

Olopatadine Hydrochloride

Carbinoxamine

Clemastine Fumarate

Cyproheptadine Hydrochloride

Diphenhydramine Hydrochloride

Hydroxyzine Hydrochloride

Hydroxyzine Pamoate

Promethazine Hydrochloride

Anti-inflammatories, Inhaled

Corticosteroids

Beclomethasone Dipropionate

Dipropionate

Monohydrate

Budesonide

Ciclesonide

Flunisolide

Fluticasone Propionate

Mometasone Furoate

Monohydrate

Triamcinolone Acetonide

Antileukotrienes

Montelukast Sodium

Zafirlukast

Zileuton

Bronchodilators, Anticholinergic

Aclidinium Bromide

Ipratropium Bromide

Tiotropium Bromide

Monohydrate

Umeclidinium New FDA Approved Drug, 4/30/14

Bronchodilators, Sympathomimetic

Albuterol Sulfate

Arformoterol Tartrate

Epinephrine Bitartrate

Formoterol Fumarate

Dihydrate

Indacaterol inhalation powder Maleate

Levalbuterol Hydrochloride

Metaproterenol Sulfate

Salmeterol Xinafoate

Terbutaline Sulfate

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 37: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 37 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1682

1683

1684

1685

1686

1687

1688

1689

1690

1691

1692

1693

1694

1695

1696

1697

1698

1699

1700

1701

1702

1703

1704

1705

1706

1707

1708

1709

1710

1711

1712

1713

1714

1715

1716

1717

1718

1719

1720

1721

1722

1723

Olodaterol New FDA Approved Drug, 7/31/14

Cystic Fibrosis Agents

Ivacaftor

Ivacaftor/Lumacaftor New FDA Approved Drug, 7/2/15

Tobramycin dry-powder

inhaler

Aztreonam inhalant solution

Mast Cell Stabilizers

Cromolyn Sodium

Phosphodiesterase Inhibitors, Airways

Disease

Aminophylline Dihydrate

Dyphylline Discontinued by manufacturer

Theophylline

Roflumilast

Pulmonary Antihypertensives

Ambrisentan

Bosentan

Macitentan

Sildenafil Citrate

Tadalafil

Epoprostenol

Iloprost

Treprostinil

Riociguat

Selexipag New FDA Approved Drug, 12/21/15

Respiratory Tract Agents, Other

Acetylcysteine

Alpha-1 Proteinase Inhibitor,

Human

Reclassification; drug moved to newly

renamed category, "Genetic or Enzyme

Disorder: Replacement, Modifiers, Treatment

Budesonide/ Formoterol

fumarate

Fluticasone furoate/

Vilanterol trifenatate

Fluticasone propionate/

Salmeterol

Mometasone furoate/

Formoterol fumerate

dihydrate

Tetrahydrozoline Hydrochloride

Umeclidinum/ Vilanterol

Trifenate

New FDA Approved Drug, 12/16/13

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red

Page 38: USP Medicare Model Guidelines v7.0 Page 1 of 38 · * This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red.

USP Medicare Model Guidelines v7.0 Page 38 of 38

1

2

A B D E F

USP Category USP Class

Example Part D Eligible

Drugs* Salt/Ester Change Language

1724

1725

1726

1727

1728

1729

1730

1731

1732

1733

1734

1735

1736

1737

1738

1739

1740

1741

1742

1743

1744

1745

1746

1747

1748

1749

1750

1751

1752

1753

1754

1755

Indacaterol/Glycopyrrolate New FDA Approved Drug, 10/29/15

Mepolizumab New FDA Approved Drug, 11/4/15

Pulmonary Fibrosis Agents Nomenclature Change, New class to reflect

therapeutics

Nintedanib New FDA Approved Drug, 10/15/14

Pirfenidone New FDA Approved Drug, 10/15/14

Skeletal Muscle Relaxants

Skeletal Muscle Relaxants Cyclobenzaprine Hydrochloride

Skeletal Muscle Relaxants Metaxalone

Skeletal Muscle Relaxants Methocarbamol

Skeletal Muscle Relaxants Orphenadrine Citrate

Skeletal Muscle Relaxants Carisoprodol

Skeletal Muscle Relaxants Chlorzoxazone

Skeletal Muscle Relaxants Orphenadrine Hydrochloride

Sleep Disorder Agents

Sleep Disorder Agents GABA Receptor Modulators

Sleep Disorder Agents

Sleep Disorder Agents Flurazepam

Sleep Disorder Agents Temazepam

Sleep Disorder Agents Quazepam*

Sleep Disorder Agents

Sleep Disorder Agents Eszopiclone

Sleep Disorder Agents Zaleplon

Sleep Disorder Agents Zolpidem Tartrate

Sleep Disorder Agents Sleep Disorders, Other

Sleep Disorder Agents Armodafinil

Sleep Disorder Agents Doxepin Hydrochloride

Sleep Disorder Agents Modafinil

Sleep Disorder Agents Sodium Oxybate

Sleep Disorder Agents Suvorexant

Sleep Disorder Agents Tasimelteon New FDA Approved Drug, 1/31/14

Sleep Disorder Agents Ramelteon

* This list is illustrative of Part D eligible drugs only, and does not infer CMS coverage Changes from USP MMG v6.0 marked in red